Cite
APA Citation
LoRusso, P., Miller, K., Shields, A., Saito, K., Yoshida, K., Aoyama, T., Winkler, R., Benedetti, F., & Lenz, H. (n.d.). phase 1 Study of first-in-class dUTPase inhibitor, TAS-114 in combination with capecitabine in patients with advanced solid tumors. European journal of cancer, 69, S119–. http://access.bl.uk/ark:/81055/vdc_100039473424.0x000056